We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+15.25%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$496M
AUM Growth
+$65.1M
Cap. Flow
+$6.19M
Cap. Flow %
1.25%
Top 10 Hldgs %
46.44%
Holding
113
New
19
Increased
12
Reduced
22
Closed
15

Top Buys

Rank Stock Value
1
SDGR icon
Schrodinger
SDGR
+$9.04M
2
V icon
Visa
V
+$8.81M
3
CELL
PhenomeX Inc. Common Stock
CELL
+$8.63M
4
PANW icon
Palo Alto Networks
PANW
+$8.53M
5
ANSS
Ansys
ANSS
+$8.27M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$10.8M
2
AMGN icon
Amgen
AMGN
+$9.67M
3
MRK icon
Merck
MRK
+$8.52M
4
COR icon
Cencora
COR
+$7.93M
5
MMM icon
3M
MMM
+$7.59M

Sector Composition

Rank Sector Weight
1 Healthcare 36.85%
2 Technology 22.93%
3 Industrials 11.94%
4 Communication Services 8.59%
5 Financials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$62.6M 12.63%
370,764
+36,040
+11% +$5.38M
AAPL icon
2
Apple
AAPL
$4.67T
$49.9M 10.07%
375,998
+5,005
+1% +$602K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.24T
$19.8M 3.99%
225,920
+140
+0.1% +$11.8K
TMO icon
4
Thermo Fisher Scientific
TMO
$230B
$17.3M 3.49%
37,094
UNH icon
5
UnitedHealth
UNH
$353B
$15.7M 3.16%
44,627
AKAM icon
6
Akamai
AKAM
$15.4B
$13.7M 2.76%
130,374
+61,829
+90% +$6.47M
ABBV icon
7
AbbVie
ABBV
$451B
$13.6M 2.74%
126,882
CSCO icon
8
Cisco
CSCO
$433B
$12.9M 2.59%
287,271
-29,491
-9% -$1.21M
CI icon
9
Cigna
CI
$73.7B
$12.5M 2.51%
59,873
-50
-0.1% -$9.81K
META icon
10
Meta Platforms (Facebook)
META
$1.47T
$12.4M 2.5%
45,296
-273
-0.6% -$74.8K
XPO icon
11
XPO
XPO
$22.1B
$11.9M 2.39%
287,809
-2,646
-0.9% -$95.9K
LAZ icon
12
Lazard
LAZ
$4.25B
$11.8M 2.37%
277,934
-10,398
-4% -$393K
LMT icon
13
Lockheed Martin
LMT
$130B
$11.4M 2.31%
32,215
-845
-3% -$311K
SDGR icon
14
Schrodinger
SDGR
$1.47B
$11.4M 2.3%
+143,750
New +$9.04M
AMZN icon
15
Amazon
AMZN
$2.87T
$10.8M 2.19%
66,560
+41,260
+163% +$6.58M
PANW icon
16
Palo Alto Networks
PANW
$303B
$10.8M 2.18%
+182,490
New +$8.53M
DOV icon
17
Dover
DOV
$26.8B
$10.8M 2.18%
85,402
-1,100
-1% -$131K
DHR icon
18
Danaher
DHR
$152B
$10M 2.02%
50,917
EMN icon
19
Eastman Chemical
EMN
$8.35B
$9.81M 1.98%
97,790
-1,530
-2% -$142K
CACI icon
20
CACI
CACI
$13.9B
$9.79M 1.98%
39,273
+18,550
+90% +$4.27M
EPD icon
21
Enterprise Products Partners
EPD
$84.3B
$9.47M 1.91%
483,545
-12,000
-2% -$223K
V icon
22
Visa
V
$712B
$9.41M 1.9%
+43,036
New +$8.81M
BX icon
23
Blackstone
BX
$107B
$9.24M 1.86%
142,563
-250
-0.2% -$14.6K
CELL
24
DELISTED
PhenomeX Inc. Common Stock
CELL
$9.17M 1.85%
+102,583
New +$8.63M
CERN
25
DELISTED
Cerner Corp
CERN
$9.1M 1.84%
115,895
-330
-0.3% -$24.5K

Similar funds

Private Capital Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Private Capital Advisors held 113 positions worth $496M, up 15% from $431M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Private Capital Advisors's Q4 2020 filing shows 19 new, 12 increased, 22 reduced and 15 closed positions. Its largest new stake was Schrodinger: 143,750 shares worth $11.4M. The largest sale was Intel, an estimated $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 37% a quarter earlier, followed by Technology and Industrials.

  • Private Capital Advisors's largest Q4 2020 buy was Schrodinger: 143,750 shares worth $11.4M.
  • Private Capital Advisors added most to Amazon in Q4 2020, an estimated $6.58M increase.
  • Private Capital Advisors's biggest Q4 2020 reduction was Bath & Body Works, cutting an estimated $1.94M.
  • Private Capital Advisors fully exited Intel in Q4 2020, selling an estimated $10.8M.
  • Private Capital Advisors's ten largest holdings make up 46% of its $496M portfolio in Q4 2020.
  • Private Capital Advisors opened 19 new positions and closed 15 in Q4 2020.
  • Private Capital Advisors's portfolio value rose 15% quarter-over-quarter to $496M.

Based on Private Capital Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.